Patent US5487972A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5487972A Expired / Lapsed US ⏱️ 0.0 years remaining

Nucleic acid detection by the 5'-3'exonuclease activity of polymerases acting on adjacently hybridized oligonucleotides

Assignee: Roche Molecular Systems Inc
•
Filing: 1993-01-05
•
Granted: 1996-01-30
•
Expires: 2013-01-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process of detecting a target nucleic acid using labeled oligonucleotides which uses the 5' to 3' nuclease activity of a nucleic acid polymerase to cleave annealed labeled oligonucleotide from hybridized duplexes and thus releasing labeled oligonucleotide fragments for detection. This process is easily incorporated into a PCR amplification assay.

Inventors

  • 👤 David H. Gelfand
  • 👤 Pamela M. Holland
  • 👤 Randall K. Saiki
  • 👤 Robert M. Watson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 11:57
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6844; C12Q1/686; C07; C07H; C07H21/00; C12Q1/6813; C12Q1/6816; C12Q1/6818; C12Q1/6823; C12Q1/6827; C12Q1/70; C12Q1/701; C12Q1/702; C12Q1/703; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/81; Y10S436/00; Y10S436/815

Claims Analysis

Total Claims: 35
Claim 1
Independent Claim 197 words
A process for the detection or measurement of a target nucleic acid sequence in a sample, said process comprising: (a) contacting a sample comprising single-stranded nucleic acids with an oligonucleotide containing a sequence complementary to a region of the target nucleic acid and a labeled oligonucleotide containing a sequence complementary to a second region of the same target nucleic acid sequence strand, but not including the nucleic acid sequence defined by the fast oligonucleotide, to create a mixture of duplexes during hybridization conditions, if the target nucleic acid sequence is present in the sample, wherein the duplexes comprise the target nucleic acid annealed to the fast oligonucleotide and to the labeled oligonucleotide such that the 3' end of the first oligonucleotide is adjacent to the 5' end of the labeled oligonucleotide; (b) maintaining the mixture of step (a) with a template-dependent nucleic acid polymerase having a 5' to 3' nuclease activity under conditions sufficient to permit the 5' to 3' nuclease activity of the polymerase to cleave the annealed, labeled oligonucleotide and release labeled fragments; and (c) detecting and/or measuring the release of labeled fragments and thereby detecting and/or measuring the target nucleic acid in the sample.
Claim 2
Dependent Claim 197 words
A process for the detection or measurement of a target nucleic acid sequence in a sample, said process comprising: (a) contacting a sample comprising single-stranded nucleic acids with an oligonucleotide containing a sequence complementary to a region of the target nucleic acid and a labeled oligonucleotide containing a sequence complementary to a second region of the same target nucleic acid sequence strand, but not including the nucleic acid sequence defined by the fast oligonucleotide, to create a mixture of duplexes during hybridization conditions, if the target nucleic acid sequence is present in the sample, wherein the duplexes comprise the target nucleic acid annealed to the fast oligonucleotide and to the labeled oligonucleotide such that the 3' end of the first oligonucleotide is adjacent to the 5' end of the labeled oligonucleotide; (b) maintaining the mixture of step (a) with a template-dependent nucleic acid polymerase having a 5' to 3' nuclease activity under conditions sufficient to permit the 5' to 3' nuclease activity of the polymerase to cleave the annealed, labeled oligonucleotide and release labeled fragments; and (c) detecting and/or measuring the release of labeled fragments and thereby detecting and/or measuring the target nucleic acid in the sample.
Claim 3
Dependent Claim 47 words
The process of claim 1 wherein the 3' end of the first oligonucleotide in the annealed duplex of step (a) is adjacent the 5' end of an annealed, labeled oligonucleotide, having spacing effective to permit the release of labeled fragments in the absence of nucleic acid polymerization.
Claim 4
Dependent Claim 10 words
The process of claim 1 wherein the oligonucleotides comprise deoxyribonucleotides.
Claim 5
Dependent Claim 21 words
The process of claim 1 wherein the nucleic acid polymerase is a DNA polymerase having a 5' to 3' nuclease activity.
Claim 6
Dependent Claim 19 words
The process of claim 1 wherein a nucleotide within the labeled oligonucleotide is modified to control nuclease cleavage specificity.
Claim 7
Dependent Claim 30 words
The process of claim 1 wherein the labeled oligonucleotide comprises first and second labels wherein the first label is separated from the second label by a nuclease susceptible cleavage site.
Claim 8
Dependent Claim 15 words
The process of claim 1 wherein the labeled oligonucleotide is labeled at the 5' terminus.
Claim 9
Dependent Claim 30 words
The process of claim 6 wherein the labeled oligonucleotide further comprises a tail of non-nucleic acids or a sequence of nucleotides which is non-complementary to the target nucleic acid sequence.
Claim 10
Dependent Claim 19 words
The process of claim 8 wherein the label is attached to a nucleotide in the tail or non-complementary sequence.
Claim 11
Dependent Claim 32 words
The process of claim 9 wherein the label is at the 5' terminus and is separated from the sequence complementary to the target nucleic acid sequence by the tail or non-complementary sequence.
Claim 12
Dependent Claim 27 words
The process of claim 1 performed under conditions sufficient to promote nucleic acid polymerization, wherein the release of labeled fragments occurs during extension of the first oligonucleotide.
Claim 13
Dependent Claim 14 words
The process of claim 1 wherein said nucleic acid polymerase is a thermostable enzyme.
Claim 14
Dependent Claim 17 words
The process of claim 12 wherein said thermostable enzyme is the DNA polymerase from a Thermus species.
Claim 15
Dependent Claim 22 words
The process of claim 1 wherein said labeled oligonucleotide has a blocked 3' terminus to prevent extension by the nucleic acid polymerase.
Claim 16
Dependent Claim 17 words
The process of claim I wherein the label is attached to an internal sequence of the oligonucleotide.
Claim 17
Dependent Claim 14 words
The process of claim 1 wherein the label is deoxyribonucleoside analog having signal-generating properties.
Claim 18
Dependent Claim 79 words
The process of claim 1 wherein the labeled oligonucleotide comprises a pair of interactive signal-generating labels effectively positioned on the oligonucleotide to quench the generation of detectable signal, said labels being separated by a site within the oligonucleotide susceptible to nuclease cleavage, thereby allowing, the 5' to 3' nuclease activity of the nucleic acid polymerase to separate the first interactive signal-generating label from the second interactive signal-generating label by cleaving at the susceptible site thereby yielding a detectable signal.
Claim 19
Dependent Claim 23 words
The process of claim 17 wherein said first label is a chemiluminescent substrate and said second label is a fluorophore which interacts therewith.
Claim 20
Dependent Claim 20 words
The process of claim 1 wherein the labeled oligonucleotide fragments comprise a mixture of mono-, di-, and larger nucleotide fragments.
Claim 21
Dependent Claim 24 words
The process of claim 1 which further comprises separating labeled oligonucleotide fragments from other components in the mixture prior to detection of labeled fragments.
Claim 22
Dependent Claim 13 words
The process of claim 20 wherein the separation step uses size exclusion chromatography.
Claim 23
Dependent Claim 18 words
The process of claim 20 wherein the labeled fragments are separated from the mixture by solid phase extraction.
Claim 24
Dependent Claim 35 words
The process of claim 22 wherein avidin or streptavidin is attached to the solid phase and the labeled oligonucleotide further comprises a bound biotin molecule separated from the labeled by a nuclease susceptible cleavage site.
Claim 25
Dependent Claim 222 words
A process for the detection or measurement of a target nucleic acid sequence in a sample, said process comprising: (a) contacting a sample comprising single-stranded nucleic acids with an oligonucleotide containing a sequence complementary to a region of the target nucleic acid and a labeled oligonucleotide containing a sequence complementary to a second region of the same target nucleic acid sequence strand, but not including the nucleic acid sequence defined by the first oligonucleotide, to create a mixture of duplexes during hybridization conditions, if the target nucleic acid sequence is present in the sample, wherein the duplexes comprise the target nucleic acid annealed to the first oligonucleotide and to the labeled oligonucleotide such that the 3' end of the first oligonucleotide is upstream of the 5' end of the labeled oligonucleotide, wherein said labeled oligonucleotide further comprises a tail of non-nucleic acids or a sequence of nucleotides which is non-complementary to the target nucleic acid sequence; (b) maintaining the mixture of step (a) with a template-dependent nucleic acid polymerase having a 5' to 3' nuclease activity under conditions sufficient to permit the 5' to 3' nuclease activity of the polymerase to cleave the annealed, labeled oligonucleotide and release labeled fragments; and (c) detecting and/or measuring the release of labeled fragments and thereby detecting and/or measuring the target nucleic acid in the sample.
Claim 26
Dependent Claim 222 words
A process for the detection or measurement of a target nucleic acid sequence in a sample, said process comprising: (a) contacting a sample comprising single-stranded nucleic acids with an oligonucleotide containing a sequence complementary to a region of the target nucleic acid and a labeled oligonucleotide containing a sequence complementary to a second region of the same target nucleic acid sequence strand, but not including the nucleic acid sequence defined by the first oligonucleotide, to create a mixture of duplexes during hybridization conditions, if the target nucleic acid sequence is present in the sample, wherein the duplexes comprise the target nucleic acid annealed to the first oligonucleotide and to the labeled oligonucleotide such that the 3' end of the first oligonucleotide is upstream of the 5' end of the labeled oligonucleotide, wherein said labeled oligonucleotide further comprises a tail of non-nucleic acids or a sequence of nucleotides which is non-complementary to the target nucleic acid sequence; (b) maintaining the mixture of step (a) with a template-dependent nucleic acid polymerase having a 5' to 3' nuclease activity under conditions sufficient to permit the 5' to 3' nuclease activity of the polymerase to cleave the annealed, labeled oligonucleotide and release labeled fragments; and (c) detecting and/or measuring the release of labeled fragments and thereby detecting and/or measuring the target nucleic acid in the sample.
Claim 27
Dependent Claim 15 words
The process of claim 24 wherein the labeled oligonucleotide is labeled at the 5' terminus.
Claim 28
Dependent Claim 19 words
The process of claim 24 wherein the label is attached to a nucleotide in the tail or noncomplementary sequence.
Claim 29
Dependent Claim 316 words
A polymerase chain reaction (PCR) amplification process for detecting a target nucleic acid sequence in a sample, said process comprising: (a) providing to a PCR assay containing said sample, a least one labeled oligonucleotide containing a sequence complementary to a region of the target nucleic acid, wherein said labeled oligonucleotide anneals within the target nucleic acid sequence bounded by the oligonucleotide primers of step (b); (b) providing a set of oligonucleotide primers, wherein a first primer contains a sequence complementary to a region in one strand of the target nucleic acid sequence and primes the synthesis of a complementary DNA strand, and a second primer contains a sequence complementary to a region in a second strand of the target nucleic acid sequence and primes the synthesis of a complementary DNA strand; and wherein each oligonucleotide primer is selected to anneal to its complementary template upstream of any labeled oligonucleotide annealed to the same nucleic acid strand and wherein the 3' end of an annealed oligonucleotide primer is adjacent to the 5' end of said labeled oligonucleotide annealed to the same nucleic acid strand; (c) amplifying the target nucleic acid sequence, if the target sequence is present in the sample, employing a nucleic acid polymerase having 5' to 3' nuclease activity as a template-dependent polymerizing agent under conditions which are permissive for PCR cycling steps of (i) annealing of primers and labeled oligonucleotide to a template nucleic acid sequence contained within the target sequence, and (ii) extending the primer wherein said nucleic acid polymerase synthesizes a primer extension product while the 5' to 3' nuclease activity of the nucleic acid polymerase simultaneously releases labeled fragments from the annealed duplexes comprising labeled oligonucleotide and its complementary template nucleic acid sequences, thereby creating detectable labeled fragments; and (d) detecting and/or measuring the release of labeled fragments to determine the presence or absence of the target sequence in the sample.
Claim 30
Dependent Claim 316 words
A polymerase chain reaction (PCR) amplification process for detecting a target nucleic acid sequence in a sample, said process comprising: (a) providing to a PCR assay containing said sample, a least one labeled oligonucleotide containing a sequence complementary to a region of the target nucleic acid, wherein said labeled oligonucleotide anneals within the target nucleic acid sequence bounded by the oligonucleotide primers of step (b); (b) providing a set of oligonucleotide primers, wherein a first primer contains a sequence complementary to a region in one strand of the target nucleic acid sequence and primes the synthesis of a complementary DNA strand, and a second primer contains a sequence complementary to a region in a second strand of the target nucleic acid sequence and primes the synthesis of a complementary DNA strand; and wherein each oligonucleotide primer is selected to anneal to its complementary template upstream of any labeled oligonucleotide annealed to the same nucleic acid strand and wherein the 3' end of an annealed oligonucleotide primer is adjacent to the 5' end of said labeled oligonucleotide annealed to the same nucleic acid strand; (c) amplifying the target nucleic acid sequence, if the target sequence is present in the sample, employing a nucleic acid polymerase having 5' to 3' nuclease activity as a template-dependent polymerizing agent under conditions which are permissive for PCR cycling steps of (i) annealing of primers and labeled oligonucleotide to a template nucleic acid sequence contained within the target sequence, and (ii) extending the primer wherein said nucleic acid polymerase synthesizes a primer extension product while the 5' to 3' nuclease activity of the nucleic acid polymerase simultaneously releases labeled fragments from the annealed duplexes comprising labeled oligonucleotide and its complementary template nucleic acid sequences, thereby creating detectable labeled fragments; and (d) detecting and/or measuring the release of labeled fragments to determine the presence or absence of the target sequence in the sample.
Claim 31
Dependent Claim 23 words
The PCR process of claim 27 wherein said labeled oligonucleotide has a blocked 3' terminus to prevent extension by the nucleic acid polymerase.
Claim 32
Dependent Claim 31 words
The PCR process of claim 27 wherein the labeled oligonucleotide further comprises a sequence of one to about ten nucleotides which sequence is substantially non-complementary to the target nucleic acid sequence.
Claim 33
Dependent Claim 18 words
The PCR process of claim 29 wherein the label is attached to a nucleotide in the non-complementary sequence.
Claim 34
Dependent Claim 26 words
The PCR process of claim 30 wherein the label is at the 5' terminus and is separated from the complementary probe sequence by the non-complementary sequence.
Claim 35
Dependent Claim 16 words
The PCR process of claim 28 wherein the oligonucleotide is labeled at the blocked 3' terminus.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-01-29 1999-07-31 2000-01-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-01-29 2003-07-31 2004-01-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-01-29 2007-07-31 2008-01-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag